US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Enliven Treateutics

54.32

-1.9100-3.40%

Post-market: 54.320.00000.00%19:56 EDT

Volume:995.81K

Turnover:54.45M

Market Cap:3.98B

PE:-32.42

High:57.00

Open:57.00

Low:54.12

Close:56.23

52wk High:62.32

52wk Low:14.79

Shares:73.27M

Float Shares:61.73M

Volume Ratio:0.94

T/O Rate:1.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6753

EPS(LYR):-1.8300

ROE:-15.31%

ROA:-11.00%

PB:4.45

PE(LYR):-29.68

Loading ...

Overview Company News Filings

Press Release: Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

Merck comments on TERN-701 positive for Enliven’s ELVN-001, says Mizuho

Enliven price target raised to $55 from $36 at Clear Street

Enliven CMO Helen Louise Collins disposes of shares worth $239,842

Enliven Therapeutics announces annual shareholder meeting

Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)

U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin

Leveraging Merck–Terns Benchmark: Supporting Enliven’s ELVN-001 Upside and a Raised $60 Buy Target

JonesTrading Keeps Their Buy Rating on Enliven Therapeutics (ELVN)

LifeSci Capital Keeps Their Buy Rating on Enliven Therapeutics (ELVN)

Enliven Therapeutics; Chief Medical Officer Helen Louise Collins disposes of 40,000 common shares valued at $1,404,024

Enliven rises 11.0%

Enliven Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $56 From $48

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

BUZZ-Enliven gains after Jones raises PT on increased takeover appeal

Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck

U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources

Enliven Therapeutics CMO Helen Louise Collins disposes of USD 138,800 in common shares

Enliven Therapeutics CMO Helen Louise Collins Disposes of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/ELVN/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ELVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","market":"US","secType":"STK","nameCN":"Enliven Treateutics","latestPrice":54.32,"timestamp":1789156800000,"preClose":56.23,"halted":0,"volume":995813,"hourTrading":{"tag":"盘后","latestPrice":54.32,"preClose":54.32,"latestTime":"19:56 EDT","volume":195442,"amount":10616418.304,"timestamp":1789171012845,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03396763293615502,"floatShares":61725902,"shares":73270761,"eps":-1.67535,"marketStatus":"Market Closed","change":-1.91,"latestTime":"09-11 16:00:00 EDT","open":57,"high":57,"low":54.12,"amount":54449600.95302,"amplitude":0.051218,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.67535,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1583985600000,"exchange":"NASDAQ","adjPreClose":56.23,"preHourTrading":{"tag":"盘前","latestPrice":56.26,"preClose":56.23,"latestTime":"09:00 EDT","volume":390,"amount":22042.41,"timestamp":1789131657877,"change":0.03,"changeRate":0.000534,"amplitude":0.013338},"postHourTrading":{"tag":"盘后","latestPrice":54.32,"preClose":54.32,"latestTime":"19:56 EDT","volume":195442,"amount":10616418.304,"timestamp":1789171012845,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.937911,"impliedVol":0.6113,"impliedVolPercentile":0.3745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","floatShares":61725902,"roa":"-11.00%","roe":"-15.31%","lyrEps":-1.83,"volumeRatio":0.937911,"shares":73270761,"dividePrice":0,"high":57,"amplitude":0.051218,"preClose":56.23,"low":54.12,"week52Low":14.785,"pbRate":"4.45","week52High":62.32,"institutionHeld":0,"latestPrice":54.32,"eps":-1.67535,"divideRate":0,"volume":995813,"delay":0,"ttmEps":-1.67535,"open":57,"prevYearClose":15.4,"prevWeekClose":59.32,"prevMonthClose":57.89,"prevQuarterClose":50.75,"fiveDayClose":59.65,"twentyDayClose":58.06,"sixtyDayClose":42.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"ELVN","fiscalQuarterEnding":"2026/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-05-07","symbol":"ELVN","fiscalQuarterEnding":"2026/03","expectedEps":-0.44,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2026-03-03","symbol":"ELVN","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-11-12","symbol":"ELVN","fiscalQuarterEnding":"2025/09","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2025-08-13","symbol":"ELVN","fiscalQuarterEnding":"2025/06","expectedEps":-0.53,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELVN","date":"2026-09-10","current":-32.423076,"percent":0.027842,"low":-43.197129,"twenty":-20.927476,"median":-13.187343,"eighty":-10.933345,"high":-6.665619,"avg":-15.916303,"sd":7.500257,"marketCap":4209405219},"quantilePoints":[{"date":"2023-02-24","current":-26.682642,"twenty":-26.682642,"median":-26.682642,"eighty":-26.682642,"marketCap":974023148},{"date":"2023-03-03","current":-24.8289,"twenty":-26.345598,"median":-24.559265,"eighty":-24.199752,"marketCap":906354172},{"date":"2023-03-10","current":-23.694186,"twenty":-25.199648,"median":-24.28963,"eighty":-23.806534,"marketCap":864932556},{"date":"2023-03-17","current":-24.997422,"twenty":-25.053596,"median":-24.508708,"eighty":-23.817768,"marketCap":912505897},{"date":"2023-03-24","current":-25.045524,"twenty":-25.045524,"median":-24.501056,"eighty":-23.817768,"marketCap":943264523},{"date":"2023-03-31","current":-23.847695,"twenty":-25.154418,"median":-24.513309,"eighty":-23.847695,"marketCap":898151871},{"date":"2023-04-06","current":-25.11086,"twenty":-25.119572,"median":-24.513309,"eighty":-23.847695,"marketCap":945725213},{"date":"2023-04-14","current":-20.962015,"twenty":-25.076502,"median":-24.390743,"eighty":-23.811629,"marketCap":789471394},{"date":"2023-04-21","current":-21.332253,"twenty":-25.048753,"median":-24.119928,"eighty":-22.848051,"marketCap":803415304},{"date":"2023-04-28","current":-20.635334,"twenty":-25.016663,"median":-23.926845,"eighty":-21.458569,"marketCap":777167943},{"date":"2023-05-05","current":-20.341321,"twenty":-24.896309,"median":-23.847695,"eighty":-21.260383,"marketCap":766094838},{"date":"2023-05-12","current":-20.851059,"twenty":-24.795534,"median":-23.81078,"eighty":-20.994683,"marketCap":785292584},{"date":"2023-05-19","current":-21.89907,"twenty":-24.705543,"median":-23.593073,"eighty":-21.113722,"marketCap":824762787},{"date":"2023-05-26","current":-21.462399,"twenty":-24.613192,"median":-22.720646,"eighty":-21.211975,"marketCap":808316869},{"date":"2023-06-02","current":-18.734285,"twenty":-24.559265,"median":-21.980633,"eighty":-20.954392,"marketCap":819006716},{"date":"2023-06-09","current":-21.377022,"twenty":-24.515759,"median":-21.83357,"eighty":-20.954392,"marketCap":934539290},{"date":"2023-06-16","current":-18.254642,"twenty":-24.497376,"median":-21.673899,"eighty":-20.758384,"marketCap":798038170},{"date":"2023-06-23","current":-20.812737,"twenty":-24.451411,"median":-21.642525,"eighty":-20.734427,"marketCap":909870413},{"date":"2023-06-30","current":-18.32988,"twenty":-24.28963,"median":-21.616844,"eighty":-20.341321,"marketCap":801327354},{"date":"2023-07-07","current":-17.361189,"twenty":-24.217728,"median":-21.517191,"eighty":-20.09872,"marketCap":758979115},{"date":"2023-07-14","current":-17.135475,"twenty":-24.135893,"median":-21.462399,"eighty":-19.332427,"marketCap":749111564},{"date":"2023-07-21","current":-17.972499,"twenty":-24.119928,"median":-21.435107,"eighty":-18.517975,"marketCap":785703732},{"date":"2023-07-28","current":-16.984999,"twenty":-23.971833,"median":-21.377022,"eighty":-18.220785,"marketCap":742533197},{"date":"2023-08-04","current":-16.881547,"twenty":-23.922067,"median":-21.256028,"eighty":-17.820142,"marketCap":738010570},{"date":"2023-08-11","current":-16.491696,"twenty":-23.861932,"median":-21.016461,"eighty":-17.568094,"marketCap":720967464},{"date":"2023-08-18","current":-12.980214,"twenty":-23.847695,"median":-20.922018,"eighty":-17.248332,"marketCap":669117064},{"date":"2023-08-25","current":-13.578933,"twenty":-23.823753,"median":-20.812737,"eighty":-17.129832,"marketCap":699980398},{"date":"2023-09-01","current":-12.469308,"twenty":-23.815574,"median":-20.736061,"eighty":-17.000046,"marketCap":642780353},{"date":"2023-09-08","current":-12.908368,"twenty":-23.809931,"median":-20.564155,"eighty":-16.862737,"marketCap":665413464},{"date":"2023-09-15","current":-13.123907,"twenty":-23.739125,"median":-20.333094,"eighty":-16.776213,"marketCap":676524264},{"date":"2023-09-22","current":-10.154264,"twenty":-23.633518,"median":-19.996164,"eighty":-15.495828,"marketCap":523442131},{"date":"2023-09-29","current":-10.968521,"twenty":-23.474031,"median":-19.373808,"eighty":-13.527842,"marketCap":565416265},{"date":"2023-10-06","current":-11.511359,"twenty":-23.372472,"median":-19.044642,"eighty":-13.224491,"marketCap":593399020},{"date":"2023-10-13","current":-9.994605,"twenty":-22.593241,"median":-18.52738,"eighty":-13.107941,"marketCap":515211909},{"date":"2023-10-20","current":-10.130315,"twenty":-22.058041,"median":-18.391011,"eighty":-12.999373,"marketCap":522207598},{"date":"2023-10-27","current":-9.555545,"twenty":-22.040989,"median":-18.292261,"eighty":-12.964248,"marketCap":492578798},{"date":"2023-11-03","current":-9.731169,"twenty":-21.920278,"median":-17.972499,"eighty":-12.485274,"marketCap":501632043},{"date":"2023-11-10","current":-7.695346,"twenty":-21.89907,"median":-17.817321,"eighty":-12.245786,"marketCap":475295332},{"date":"2023-11-17","current":-6.952736,"twenty":-21.83357,"median":-17.803213,"eighty":-11.215991,"marketCap":429428758},{"date":"2023-11-24","current":-7.786797,"twenty":-21.720035,"median":-17.492856,"eighty":-10.958941,"marketCap":480943724},{"date":"2023-12-01","current":-7.513225,"twenty":-21.68071,"median":-17.309463,"eighty":-10.760965,"marketCap":464046815},{"date":"2023-12-08","current":-7.506552,"twenty":-21.671453,"median":-17.210713,"eighty":-10.505512,"marketCap":463634696},{"date":"2023-12-15","current":-7.893557,"twenty":-21.652352,"median":-17.121368,"eighty":-10.333081,"marketCap":487537640},{"date":"2023-12-22","current":-8.620858,"twenty":-21.63925,"median":-17.013213,"eighty":-10.031327,"marketCap":532458691},{"date":"2023-12-29","current":-9.721819,"twenty":-21.630859,"median":-16.994403,"eighty":-9.985025,"marketCap":600458446},{"date":"2024-01-05","current":-9.735164,"twenty":-21.621546,"median":-16.919166,"eighty":-9.908649,"marketCap":601282686},{"date":"2024-01-12","current":-7.653347,"twenty":-21.612141,"median":-16.825118,"eighty":-9.735164,"marketCap":472701330},{"date":"2024-01-19","current":-8.547461,"twenty":-21.544748,"median":-16.787499,"eighty":-9.657763,"marketCap":527925374},{"date":"2024-01-26","current":-10.90285,"twenty":-21.510766,"median":-16.702856,"eighty":-9.657763,"marketCap":673403638},{"date":"2024-02-02","current":-10.972911,"twenty":-21.471637,"median":-15.246862,"eighty":-9.711143,"marketCap":677730895},{"date":"2024-02-09","current":-10.282309,"twenty":-21.462504,"median":-13.618847,"eighty":-9.729299,"marketCap":635076503},{"date":"2024-02-16","current":-11.543409,"twenty":-21.454109,"median":-13.399317,"eighty":-9.734365,"marketCap":712967132},{"date":"2024-02-23","current":-10.609261,"twenty":-21.445153,"median":-13.291548,"eighty":-9.761506,"marketCap":655270370},{"date":"2024-03-01","current":-10.655968,"twenty":-21.434015,"median":-13.147855,"eighty":-9.803015,"marketCap":658155208},{"date":"2024-03-08","current":-10.275636,"twenty":-21.409359,"median":-13.10395,"eighty":-9.82474,"marketCap":634664384},{"date":"2024-03-15","current":-6.665619,"twenty":-21.384546,"median":-13.044078,"eighty":-9.733566,"marketCap":477151673},{"date":"2024-03-22","current":-10.431636,"twenty":-21.350161,"median":-12.972231,"eighty":-9.727429,"marketCap":746738233},{"date":"2024-03-28","current":-10.760874,"twenty":-21.310474,"median":-12.880428,"eighty":-9.732767,"marketCap":770306384},{"date":"2024-04-05","current":-12.135517,"twenty":-21.260383,"median":-12.485274,"eighty":-9.752725,"marketCap":868708833},{"date":"2024-04-12","current":-15.541291,"twenty":-21.211975,"median":-12.53879,"eighty":-9.795033,"marketCap":1112507764},{"date":"2024-04-19","current":-11.553574,"twenty":-21.113722,"median":-12.520461,"eighty":-9.82282,"marketCap":827051011},{"date":"2024-04-26","current":-10.971645,"twenty":-20.994683,"median":-12.453342,"eighty":-9.833917,"marketCap":785394226},{"date":"2024-05-03","current":-13.724364,"twenty":-20.956933,"median":-12.42141,"eighty":-9.861485,"marketCap":982444863},{"date":"2024-05-10","current":-15.627075,"twenty":-20.927476,"median":-12.477291,"eighty":-9.897956,"marketCap":1118648510},{"date":"2024-05-17","current":-14.069999,"twenty":-20.877259,"median":-12.55712,"eighty":-9.908649,"marketCap":1119943779},{"date":"2024-05-24","current":-13.579529,"twenty":-20.83573,"median":-12.880428,"eighty":-9.913987,"marketCap":1080903320},{"date":"2024-05-31","current":-13.31952,"twenty":-20.807747,"median":-12.919935,"eighty":-9.925997,"marketCap":1060207172},{"date":"2024-06-07","current":-11.936748,"twenty":-20.777985,"median":-12.852488,"eighty":-9.949337,"marketCap":950141299},{"date":"2024-06-14","current":-13.012238,"twenty":-20.738783,"median":-12.908368,"eighty":-9.978639,"marketCap":1035748089},{"date":"2024-06-21","current":-12.433128,"twenty":-20.734427,"median":-12.823141,"eighty":-9.991412,"marketCap":989652125},{"date":"2024-06-28","current":-13.857265,"twenty":-20.713737,"median":-12.852488,"eighty":-9.999395,"marketCap":1103010568},{"date":"2024-07-05","current":-12.734501,"twenty":-20.635334,"median":-12.852488,"eighty":-10.018554,"marketCap":1013640841},{"date":"2024-07-12","current":-14.217731,"twenty":-20.492975,"median":-12.947875,"eighty":-10.03452,"marketCap":1131702953},{"date":"2024-07-15","current":-14.619562,"twenty":-20.462644,"median":-12.964248,"eighty":-10.034701,"marketCap":1163687908},{"date":"2024-08-02","current":-14.595925,"twenty":-20.432313,"median":-12.972231,"eighty":-10.034882,"marketCap":1161806440},{"date":"2024-08-09","current":-12.834959,"twenty":-20.33803,"median":-12.964248,"eighty":-10.054109,"marketCap":1021637080},{"date":"2024-08-16","current":-13.556309,"twenty":-20.306761,"median":-12.945278,"eighty":-10.088634,"marketCap":1122828410},{"date":"2024-08-23","current":-13.060138,"twenty":-20.227193,"median":-12.964248,"eighty":-10.111156,"marketCap":1081732040},{"date":"2024-08-30","current":-12.672326,"twenty":-20.030349,"median":-12.961651,"eighty":-10.130701,"marketCap":1049610739},{"date":"2024-09-06","current":-12.495529,"twenty":-19.786892,"median":-12.919935,"eighty":-10.135876,"marketCap":1034967205},{"date":"2024-09-13","current":-12.73506,"twenty":-19.581572,"median":-12.931502,"eighty":-10.154517,"marketCap":1054806832},{"date":"2024-09-20","current":-13.157091,"twenty":-19.368165,"median":-12.8873,"eighty":-10.156457,"marketCap":1089762365},{"date":"2024-09-27","current":-13.755918,"twenty":-19.332427,"median":-12.959054,"eighty":-10.16247,"marketCap":1139361432},{"date":"2024-10-04","current":-14.548651,"twenty":-19.185713,"median":-12.995005,"eighty":-10.191351,"marketCap":1205021150},{"date":"2024-10-11","current":-15.381306,"twenty":-18.794475,"median":-13.012238,"eighty":-10.271051,"marketCap":1273987472},{"date":"2024-10-18","current":-15.980134,"twenty":-18.692904,"median":-13.06278,"eighty":-10.276971,"marketCap":1323586540},{"date":"2024-10-25","current":-16.527633,"twenty":-18.517975,"median":-13.077247,"eighty":-10.282309,"marketCap":1368934258},{"date":"2024-10-31","current":-16.191149,"twenty":-18.480356,"median":-13.117169,"eighty":-10.282309,"marketCap":1341064306},{"date":"2024-11-08","current":-16.539039,"twenty":-18.452142,"median":-13.127899,"eighty":-10.308998,"marketCap":1369879003},{"date":"2024-11-15","current":-14.288385,"twenty":-18.32988,"median":-13.147855,"eighty":-10.377785,"marketCap":1217570416},{"date":"2024-11-22","current":-14.569336,"twenty":-18.254642,"median":-13.191309,"eighty":-10.377785,"marketCap":1241511408},{"date":"2024-11-29","current":-13.978765,"twenty":-18.119213,"median":-13.257473,"eighty":-10.420866,"marketCap":1191186467},{"date":"2024-12-06","current":-13.330857,"twenty":-17.99507,"median":-13.275582,"eighty":-10.465191,"marketCap":1135975609},{"date":"2024-12-13","current":-13.187514,"twenty":-17.927356,"median":-13.313517,"eighty":-10.47358,"marketCap":1123760818},{"date":"2024-12-20","current":-13.112976,"twenty":-17.840832,"median":-13.307514,"eighty":-10.475365,"marketCap":1117409126},{"date":"2024-12-27","current":-13.021237,"twenty":-17.81638,"median":-13.27352,"eighty":-10.487821,"marketCap":1109591659},{"date":"2025-01-03","current":-13.703547,"twenty":-17.808856,"median":-13.27352,"eighty":-10.502895,"marketCap":1167734067},{"date":"2025-01-10","current":-13.84689,"twenty":-17.803213,"median":-13.275582,"eighty":-10.521478,"marketCap":1179948858},{"date":"2025-01-17","current":-12.60841,"twenty":-17.759951,"median":-13.27352,"eighty":-10.564579,"marketCap":1074413060},{"date":"2025-01-24","current":-12.637079,"twenty":-17.586904,"median":-13.268745,"eighty":-10.609261,"marketCap":1076856018},{"date":"2025-01-31","current":-12.195584,"twenty":-17.492856,"median":-13.225528,"eighty":-10.642623,"marketCap":1039234460},{"date":"2025-02-07","current":-12.883628,"twenty":-17.445832,"median":-13.157091,"eighty":-10.649204,"marketCap":1097865460},{"date":"2025-02-14","current":-12.327459,"twenty":-17.361189,"median":-13.147855,"eighty":-10.655968,"marketCap":1050472069},{"date":"2025-02-21","current":-12.310258,"twenty":-17.278427,"median":-13.123907,"eighty":-10.661306,"marketCap":1049006294},{"date":"2025-02-28","current":-11.553409,"twenty":-17.220118,"median":-13.115073,"eighty":-10.671914,"marketCap":984512194},{"date":"2025-03-07","current":-12.304524,"twenty":-17.210713,"median":-13.077247,"eighty":-10.692528,"marketCap":1048517702},{"date":"2025-03-14","current":-11.168896,"twenty":-17.203189,"median":-13.06278,"eighty":-10.70156,"marketCap":994299783},{"date":"2025-03-21","current":-11.515688,"twenty":-17.148642,"median":-13.044078,"eighty":-10.73075,"marketCap":1025172571},{"date":"2025-03-28","current":-11.840461,"twenty":-17.112904,"median":-13.012192,"eighty":-10.756253,"marketCap":1054085181},{"date":"2025-04-04","current":-11.025775,"twenty":-17.062118,"median":-12.992568,"eighty":-10.756253,"marketCap":981558632},{"date":"2025-04-11","current":-8.207404,"twenty":-17.020737,"median":-12.961651,"eighty":-10.671914,"marketCap":730655976},{"date":"2025-04-17","current":-8.845942,"twenty":-17.00757,"median":-12.919935,"eighty":-10.646572,"marketCap":787501109},{"date":"2025-04-25","current":-10.073474,"twenty":-16.992523,"median":-12.900829,"eighty":-10.506428,"marketCap":896780977},{"date":"2025-05-02","current":-10.926692,"twenty":-16.945499,"median":-12.87493,"eighty":-10.47358,"marketCap":972737836},{"date":"2025-05-09","current":-10.268015,"twenty":-16.896595,"median":-12.837758,"eighty":-10.456802,"marketCap":914099729},{"date":"2025-05-16","current":-9.22086,"twenty":-16.864245,"median":-12.824716,"eighty":-10.419165,"marketCap":874414177},{"date":"2025-05-23","current":-8.677544,"twenty":-16.841798,"median":-12.774982,"eighty":-10.35027,"marketCap":822891456},{"date":"2025-05-30","current":-9.179465,"twenty":-16.826999,"median":-12.740411,"eighty":-10.284647,"marketCap":870488636},{"date":"2025-06-06","current":-11.057788,"twenty":-16.804427,"median":-12.734501,"eighty":-10.282309,"marketCap":1048610043},{"date":"2025-06-13","current":-10.172958,"twenty":-16.787499,"median":-12.717951,"eighty":-10.278305,"marketCap":964701612},{"date":"2025-06-20","current":-13.417901,"twenty":-16.781856,"median":-12.734501,"eighty":-10.282309,"marketCap":1272419584},{"date":"2025-06-27","current":-13.386798,"twenty":-16.747999,"median":-12.73478,"eighty":-10.283478,"marketCap":1269470072},{"date":"2025-07-03","current":-12.895368,"twenty":-16.702856,"median":-12.73478,"eighty":-10.288155,"marketCap":1222867778},{"date":"2025-07-11","current":-14.170598,"twenty":-16.684047,"median":-12.73506,"eighty":-10.29197,"marketCap":1343797781},{"date":"2025-07-18","current":-14.518953,"twenty":-16.539039,"median":-12.769279,"eighty":-10.308998,"marketCap":1376832318},{"date":"2025-07-25","current":-13.654285,"twenty":-16.539039,"median":-12.823141,"eighty":-10.377785,"marketCap":1294835877},{"date":"2025-08-01","current":-11.701007,"twenty":-16.527633,"median":-12.814277,"eighty":-10.377785,"marketCap":1109606508},{"date":"2025-08-08","current":-11.13493,"twenty":-16.527633,"median":-12.763576,"eighty":-10.392743,"marketCap":1055925385},{"date":"2025-08-15","current":-11.683894,"twenty":-16.52193,"median":-12.73478,"eighty":-10.409257,"marketCap":1170901400},{"date":"2025-08-22","current":-11.727119,"twenty":-16.516227,"median":-12.729357,"eighty":-10.425771,"marketCap":1175233252},{"date":"2025-08-29","current":-12.034483,"twenty":-16.491696,"median":-12.666623,"eighty":-10.431636,"marketCap":1206035736},{"date":"2025-09-05","current":-11.827604,"twenty":-16.470258,"median":-12.655877,"eighty":-10.465191,"marketCap":1185303295},{"date":"2025-09-12","current":-11.774406,"twenty":-16.437524,"median":-12.642812,"eighty":-10.47358,"marketCap":1179972096},{"date":"2025-09-19","current":-11.777361,"twenty":-16.362242,"median":-12.617902,"eighty":-10.475365,"marketCap":1180268273},{"date":"2025-09-26","current":-10.976442,"twenty":-16.281259,"median":-12.614144,"eighty":-10.477125,"marketCap":1100004107},{"date":"2025-10-03","current":-11.774406,"twenty":-16.205977,"median":-12.604497,"eighty":-10.492153,"marketCap":1179972096},{"date":"2025-10-10","current":-12.584192,"twenty":-16.158355,"median":-12.584192,"eighty":-10.509962,"marketCap":1261124795},{"date":"2025-10-17","current":-12.856091,"twenty":-16.100826,"median":-12.570656,"eighty":-10.522555,"marketCap":1288373147},{"date":"2025-10-24","current":-12.146789,"twenty":-16.047431,"median":-12.55712,"eighty":-10.547691,"marketCap":1217290490},{"date":"2025-10-31","current":-14.168299,"twenty":-16.017711,"median":-12.59139,"eighty":-10.598091,"marketCap":1419876061},{"date":"2025-11-07","current":-10.816849,"twenty":-16.012848,"median":-12.55712,"eighty":-10.635951,"marketCap":1084010510},{"date":"2025-11-14","current":-12.003893,"twenty":-15.986677,"median":-12.54534,"eighty":-10.635951,"marketCap":1202970115},{"date":"2025-11-21","current":-12.98587,"twenty":-15.975572,"median":-12.55712,"eighty":-10.647888,"marketCap":1262317432},{"date":"2025-11-28","current":-13.187343,"twenty":-15.974431,"median":-12.598588,"eighty":-10.653262,"marketCap":1281902047},{"date":"2025-12-05","current":-13.065238,"twenty":-15.940212,"median":-12.601543,"eighty":-10.659972,"marketCap":1270032583},{"date":"2025-12-12","current":-11.459557,"twenty":-15.886602,"median":-12.584192,"eighty":-10.669596,"marketCap":1113949140},{"date":"2025-12-19","current":-10.183559,"twenty":-15.842118,"median":-12.556807,"eighty":-10.629278,"marketCap":989913247},{"date":"2025-12-26","current":-10.214086,"twenty":-15.803337,"median":-12.543135,"eighty":-10.536256,"marketCap":992880613},{"date":"2026-01-02","current":-9.402087,"twenty":-15.766837,"median":-12.530924,"eighty":-10.485339,"marketCap":913948681},{"date":"2026-01-09","current":-14.194709,"twenty":-15.757712,"median":-12.525083,"eighty":-10.474026,"marketCap":1379825120},{"date":"2026-01-16","current":-15.366918,"twenty":-15.766837,"median":-12.533872,"eighty":-10.476139,"marketCap":1493771968},{"date":"2026-01-23","current":-16.502494,"twenty":-15.873654,"median":-12.554602,"eighty":-10.477453,"marketCap":1604157978},{"date":"2026-01-30","current":-15.67218,"twenty":-15.873654,"median":-12.55712,"eighty":-10.482717,"marketCap":1523445627},{"date":"2026-02-06","current":-16.478073,"twenty":-15.974431,"median":-12.601543,"eighty":-10.495828,"marketCap":1601784085},{"date":"2026-02-13","current":-16.581863,"twenty":-16.012848,"median":-12.60841,"eighty":-10.513495,"marketCap":1611873129},{"date":"2026-02-20","current":-15.971338,"twenty":-16.047431,"median":-12.614144,"eighty":-10.522555,"marketCap":1552525812},{"date":"2026-02-27","current":-18.083755,"twenty":-16.148743,"median":-12.62937,"eighty":-10.547691,"marketCap":1757867529},{"date":"2026-03-06","current":-16.891565,"twenty":-16.308347,"median":-12.642812,"eighty":-10.598091,"marketCap":1751553891},{"date":"2026-03-13","current":-16.614748,"twenty":-16.467534,"median":-12.654701,"eighty":-10.635951,"marketCap":1722849696},{"date":"2026-03-20","current":-17.329857,"twenty":-16.467534,"median":-12.66092,"eighty":-10.647888,"marketCap":1797002200},{"date":"2026-03-27","current":-22.658572,"twenty":-16.515009,"median":-12.723654,"eighty":-10.654615,"marketCap":2349557951},{"date":"2026-04-02","current":-21.793521,"twenty":-16.527633,"median":-12.734501,"eighty":-10.659972,"marketCap":2259857342},{"date":"2026-04-10","current":-26.291786,"twenty":-16.580833,"median":-12.737874,"eighty":-10.669596,"marketCap":2726300509},{"date":"2026-04-17","current":-26.147611,"twenty":-16.691571,"median":-12.769279,"eighty":-10.687954,"marketCap":2711350408},{"date":"2026-04-24","current":-25.311395,"twenty":-16.770571,"median":-12.821028,"eighty":-10.700446,"marketCap":2624639819},{"date":"2026-05-01","current":-23.777371,"twenty":-16.840911,"median":-12.830625,"eighty":-10.720149,"marketCap":2465570739},{"date":"2026-05-08","current":-23.660577,"twenty":-16.902605,"median":-12.844269,"eighty":-10.735381,"marketCap":2453459912},{"date":"2026-05-15","current":-26.562713,"twenty":-16.992523,"median":-12.857068,"eighty":-10.751632,"marketCap":2623785073},{"date":"2026-05-22","current":-26.050943,"twenty":-17.071504,"median":-12.866232,"eighty":-10.770508,"marketCap":2573233968},{"date":"2026-05-29","current":-25.064398,"twenty":-17.140318,"median":-12.883628,"eighty":-10.779257,"marketCap":2475786054},{"date":"2026-06-05","current":-21.882792,"twenty":-17.206951,"median":-12.898098,"eighty":-10.796387,"marketCap":2161516533},{"date":"2026-06-12","current":-24.885587,"twenty":-17.289838,"median":-12.908368,"eighty":-10.823355,"marketCap":2458123620},{"date":"2026-06-18","current":-27.660244,"twenty":-17.423782,"median":-12.959054,"eighty":-10.834214,"marketCap":2732195877},{"date":"2026-06-26","current":-30.286918,"twenty":-17.681151,"median":-12.983042,"eighty":-10.842708,"marketCap":2991650947},{"date":"2026-07-02","current":-34.467224,"twenty":-17.803213,"median":-13.001182,"eighty":-10.859067,"marketCap":3404568943},{"date":"2026-07-10","current":-36.884736,"twenty":-17.91607,"median":-13.012238,"eighty":-10.862815,"marketCap":3643363566},{"date":"2026-07-17","current":-35.951661,"twenty":-18.010492,"median":-13.044125,"eighty":-10.872726,"marketCap":3551197220},{"date":"2026-07-24","current":-37.330067,"twenty":-18.254642,"median":-13.065238,"eighty":-10.89369,"marketCap":3687352049},{"date":"2026-07-31","current":-38.135905,"twenty":-18.489761,"median":-13.068026,"eighty":-10.901018,"marketCap":3766950256},{"date":"2026-08-07","current":-39.727657,"twenty":-19.292928,"median":-13.08062,"eighty":-10.904296,"marketCap":4208231547},{"date":"2026-08-14","current":-40.16068,"twenty":-19.893608,"median":-13.117169,"eighty":-10.914394,"marketCap":4254100383},{"date":"2026-08-21","current":-40.755551,"twenty":-20.371092,"median":-13.127899,"eighty":-10.919864,"marketCap":4317113238},{"date":"2026-08-28","current":-41.848453,"twenty":-20.733857,"median":-13.147855,"eighty":-10.925478,"marketCap":4432881040},{"date":"2026-09-04","current":-41.260499,"twenty":-20.820401,"median":-13.159973,"eighty":-10.931096,"marketCap":4370600893},{"date":"2026-09-10","current":-39.738737,"twenty":-20.927476,"median":-13.187343,"eighty":-10.933345,"marketCap":4209405219}],"updateTime":1789193112658},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELVN\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633796461","title":"Press Release: Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633796461","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633796461?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Phase 1 data update for ELVN-001 expected mid-2026. Initiation of the Phase 3 ENABLE-2 pivotal trial of ELVN-001 expected in the second half of 2026. Strong balance sheet with $452 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into the first half of 2029. BOULDER, Colo., May 7, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.\"Recent strategic momentum in CML validates a remaining unmet need and a compelling long-term opportunity. Against this backdrop,  we remain focused on execution as we prepare to initiate the Phase 3 pivotal trial of ELVN-001 in the second half of 2026,\" said Rick Fair, Chief Executive Officer of Enliven. \"Based on the Phase 1 data generated to date, we believe ELVN-001 has the potential","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","ELVN","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632166358","title":"Merck comments on TERN-701 positive for Enliven’s ELVN-001, says Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2632166358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632166358?lang=en_us&edition=fundamental","pubTime":"2026-05-01 03:32","pubTimestamp":1777577567,"startTime":"0","endTime":"0","summary":"Mizuho reiterated an Outperform rating and $45 price target on Enliven (ELVN) after Merck (MRK) noted during its Q1 call that it believes Terns’ (T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-comments-on-tern-701-positive-for-enlivens-elvn-001-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-comments-on-tern-701-positive-for-enlivens-elvn-001-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU0320765646.SGD","LU1585245621.USD","IE00BLSP4452.SGD","LU0122379950.USD","BK4585","LU0648001328.SGD","LU2361044949.HKD","SG9999002232.USD","LU0868494708.USD","SG9999015341.SGD","SG9999013999.USD","LU2023250843.SGD","SGXZ57979304.SGD","LU1989772840.SGD","LU1201861249.SGD","LU2361045086.USD","IE00B1BXHZ80.USD","BK4516","LU0965509010.AUD","IE00B2B36J28.USD","LU0070302665.USD","LU0106261372.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0477156953.USD","LU0265550359.USD","LU1023059063.AUD","LU0208291251.USD","SG9999015358.SGD","LU2125154778.USD","LU1699723380.USD","LU0289739699.SGD","LU1066051811.HKD","LU2461242641.AUD","LU0098860793.USD","LU0266013472.USD","LU1093756325.SGD","LU2357627491.SGD","LU0265550946.USD","ELVN","LU0234572021.USD","LU2360032135.SGD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU2468319806.SGD","LU1974910355.USD","SG9999001176.USD","LU0238689110.USD","LU0432979614.USD","BK4559","LU0203345920.USD","LU0130102774.USD","IE0002141913.USD","LU1571399168.USD","IE00BBT3K403.USD","LU0965509101.SGD","IE00BFTCPJ56.SGD","BK4534","LU2106854487.HKD","LU1934455863.HKD","LU0058720904.USD","LU2125154935.USD","LU2089984988.USD","LU0942090050.USD","LU1989771016.USD","LU1983299246.USD","LU1057294990.SGD","LU1061106388.HKD","LU0211331839.USD","LU2023250504.SGD","LU0320765489.SGD","LU1093756168.USD","LU1116320901.HKD","IE00B4R5TH58.HKD","LU2112291526.USD","LU1162221912.USD","IE00BLSP4239.USD","LU1430594728.SGD","LU1929549753.HKD","LU1066051225.USD","LU0006306889.USD","LU0861579265.USD","BK4533","LU1934455194.USD","SG9999001176.SGD","LU1291159041.SGD","LU1035773651.USD","LU1941712264.USD","SG9999002224.SGD","LU1116320737.USD","IE000M9KFDE8.USD","LU1941712348.USD","LU0965509283.SGD","IE0009355771.USD","LU0985320562.USD","LU1037948541.HKD","BK4207","LU1069347547.HKD","SG9999014559.SGD","LU0859254822.USD","LU1934455277.USD","LU1066053197.SGD","LU2361044865.SGD","LU2324357040.USD","LU0130517989.USD","LU0965508806.USD","LU1989772923.USD","BK4007","LU0868494617.USD","LU1037948897.HKD","LU0980610538.SGD","LU1066051498.USD","BK4588","LU1917777945.USD","SG9999014567.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630361517","title":"Enliven price target raised to $55 from $36 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2630361517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630361517?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:20","pubTimestamp":1777281609,"startTime":"0","endTime":"0","summary":"Clear Street raised the firm’s price target on Enliven (ELVN) to $55 from $36 and keeps a Buy rating on the shares. The firm left meetings with man...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-price-target-raised-to-55-from-36-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-price-target-raised-to-55-from-36-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062311","title":"Enliven CMO Helen Louise Collins disposes of shares worth $239,842","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062311","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062311?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:40","pubTimestamp":1776818457,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics Chief Medical Officer Helen Louise Collins exercised stock options to acquire 5,000 common shares at USD 2.48 on April 17, 2026.Collins sold 5,000 common shares on April 17, 2026 at weighted average prices of USD 45.81, USD 47.39, USD 48.06.Directly held common stock position fell to 25,000 shares following transactions.Stock options beneficially owned totaled 131,268 following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL59T959:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enliven CMO Helen Louise Collins disposes of shares worth $239,842","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627237429","title":"Enliven Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627237429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627237429?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:07","pubTimestamp":1776283674,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics will hold its annual stockholder meeting in virtual format on June 9, 2026.Stockholders will vote on election of two Class III directors: Richard Fair and Lori Kunkel.Ballot includes ratification of Deloitte & Touche as independent registered public accounting firm for fiscal 2026.Shareholders will consider charter amendment to increase authorized common stock to 200,000,000 shares from 100,000,000 shares.Advisory votes cover executive compensation and frequency of future say-on-pay votes, with board recommending annual frequency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL71Tk8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626129719","title":"Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626129719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626129719?lang=en_us&edition=fundamental","pubTime":"2026-04-11 22:30","pubTimestamp":1775917808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Sol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enliven-therapeutics-elvn-viridian-therapeutics-vrdn-and-soleno-therapeutics-slno-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enliven-therapeutics-elvn-viridian-therapeutics-vrdn-and-soleno-therapeutics-slno-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","SLNO","LU0029874061.USD","BK4137","XLV","ELVN","LABU","VRDN","BK4588","HCSG","BK4585","BK4139","XBI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626678961","title":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin","url":"https://stock-news.laohu8.com/highlight/detail?id=2626678961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626678961?lang=en_us&edition=fundamental","pubTime":"2026-04-10 15:38","pubTimestamp":1775806689,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-HannifinApril 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Friday, inclu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4N40T0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABX","CBZ","LINT","GRAL","LU2211815571.USD","ELVN","FNF","ADBE","GWRE","LU2125154778.USD","LITE","STZ","IE00BGHQF748.EUR","DOW","COHX","AMP","NAKA","DAR","CC","LSCC","IE00B2B36J28.USD","ADSK","BK4592","ALAB","HUBS","LFUS","CL","INFQ","CVX","CCC","CLF","CAI","ITW","LITX","CE","DOCU","ESAB","FRPT","INTC","DFTX","INTW","ADBG","HRI","COHR","AIM","DE","ABBV","ASRT","BRBR","AMPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625656189","title":"Leveraging Merck–Terns Benchmark: Supporting Enliven’s ELVN-001 Upside and a Raised $60 Buy Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2625656189","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625656189?lang=en_us&edition=fundamental","pubTime":"2026-04-08 03:45","pubTimestamp":1775591126,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $60.00. Sam Slutsky has given h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/leveraging-merck-terns-benchmark-supporting-enlivens-elvn-001-upside-and-a-raised-60-buy-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/leveraging-merck-terns-benchmark-supporting-enlivens-elvn-001-upside-and-a-raised-60-buy-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1069347547.HKD","SG9999015358.SGD","LU0477156953.USD","LU1989771016.USD","SGXZ57979304.SGD","LU0980610538.SGD","LU0965509010.AUD","LU2112291526.USD","LU0265550946.USD","LU1291159041.SGD","SG9999001176.USD","IE00B2B36J28.USD","SG9999002224.SGD","LU2324357040.USD","LU0965509101.SGD","LU1989772840.SGD","LU2106854487.HKD","LU0130517989.USD","LU0208291251.USD","IE00BLSP4239.USD","LU2125154778.USD","LU0058720904.USD","LU1989772923.USD","LU0070302665.USD","LU2023250504.SGD","LU0130102774.USD","BK4585","LU0861579265.USD","LU0106261372.USD","BK4534","LU1983299246.USD","LU2361045086.USD","BK4588","LU0985320562.USD","LU1093756168.USD","LU1116320901.HKD","LU0234572021.USD","IE00BSNM7G36.USD","LU1201861249.SGD","LU0868494708.USD","LU1585245621.USD","LU2361044949.HKD","LU1934455863.HKD","LU1037948897.HKD","BK4516","LU1066051498.USD","LU1941712348.USD","LU1066051225.USD","SG9999014567.USD","IE0009355771.USD","IE0002141913.USD","LU2023250843.SGD","LU0098860793.USD","LU0122379950.USD","LU0965509283.SGD","LU1057294990.SGD","LU0006306889.USD","LU1037948541.HKD","LU0265550359.USD","LU0320765646.SGD","LU0289739699.SGD","LU2468319806.SGD","IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","LU0942090050.USD","LU1061106388.HKD","LU2125154935.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0238689110.USD","SG9999001176.SGD","SG9999013999.USD","LU1116320737.USD","LU1934455277.USD","SG9999014559.SGD","LU1699723380.USD","LU1929549753.HKD","IE00BLSP4452.SGD","LU0432979614.USD","LU1162221912.USD","LU1023059063.AUD","LU1093756325.SGD","LU1066051811.HKD","LU1941712264.USD","LU0211331839.USD","BK4559","LU0320765489.SGD","IE00BBT3K403.USD","BK4007","LU1066053197.SGD","LU0648001328.SGD","BK4533","IE00BJJMRZ35.SGD","LU0868494617.USD","IE00B1BXHZ80.USD","SG9999002232.USD","LU0203345920.USD","SG9999015341.SGD","SG9999014542.SGD","BK4550","LU1430594728.SGD","LU2461242641.AUD","LU1917777945.USD","LU0266013472.USD","LU1571399168.USD","LU1934455194.USD","LU1974910355.USD","LU2360032135.SGD","LU0203347892.USD","LU2361044865.SGD","ELVN","LU1035773651.USD","SG9999014575.USD","IE000M9KFDE8.USD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625017036","title":"JonesTrading Keeps Their Buy Rating on Enliven Therapeutics (ELVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625017036","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625017036?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:35","pubTimestamp":1775507754,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Enliven Therapeutics, with a price target of $45.00. According ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-keeps-their-buy-rating-on-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-keeps-their-buy-rating-on-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384735","title":"LifeSci Capital Keeps Their Buy Rating on Enliven Therapeutics (ELVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384735","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384735?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:36","pubTimestamp":1774708610,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $53.00. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622631803","title":"Enliven Therapeutics; Chief Medical Officer Helen Louise Collins disposes of 40,000 common shares valued at $1,404,024","url":"https://stock-news.laohu8.com/highlight/detail?id=2622631803","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622631803?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:58","pubTimestamp":1774645083,"startTime":"0","endTime":"0","summary":"Helen Louise Collins, Chief Medical Officer at Enliven Therapeutics, reported an option exercise for 40,000 common shares at USD 2.48 on March 25, 2026.She also reported selling 40,000 common shares at a weighted average price of USD 35.1 on March 25, 2026.Following the reported transactions, Collins beneficially owned 25,000 common shares.After the option exercise, she reported beneficial ownership of 136,268 stock options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL1Qvlky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enliven Therapeutics; Chief Medical Officer Helen Louise Collins disposes of 40,000 common shares valued at $1,404,024","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622862211","title":"Enliven rises 11.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622862211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622862211?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:07","pubTimestamp":1774541258,"startTime":"0","endTime":"0","summary":"Enliven (ELVN) is up 11.0%, or $3.92 to $39.45. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-rises-11-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-rises-11-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622885686","title":"Enliven Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $56 From $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2622885686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622885686?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:13","pubTimestamp":1774520006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nAZN4SND6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622400500","title":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings","url":"https://stock-news.laohu8.com/highlight/detail?id=2622400500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622400500?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:47","pubTimestamp":1774460843,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKingsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL6N40D0LO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","IMNN","SIDU","PAYX","BZAI","NBHC","BWXT","GPRO","SRPT","NOV","RGR","BEAM","CTAS","VLO","SLG","BG","TXG","VNO","ADMA","MPC","BXP","PSX","KBH","DVN","DINO","CORT","JBLU","LMT","SATL","ELVN","TERN","ARE","DKNG","GNRC","CHWY","LBRT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622179076","title":"BUZZ-Enliven gains after Jones raises PT on increased takeover appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2622179076","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622179076?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:56","pubTimestamp":1774443394,"startTime":"0","endTime":"0","summary":"BUZZ-Enliven gains after Jones raises PT on increased takeover appeal** Shares of drug developer Enliven Therapeutics ELVN.O rise 14.13% to $35.55 premarket ** Jones Trading raises PT to $45 from $35 and reiterates a \"buy\" rating ** Brokerage says Merck's MRK.N $6.7 billion deal to buy rival Terns Pharmaceuticals TERN.O means that both ELVN and TERN could \"carve out their own market share\" and increase ELVN's takeover appeal** Both TERN and ELVN are developing drugs for chronic myeloid leukemia , a cancer that starts in the bone marrow and causes uncontrolled growth of leukemia cells** Brokerage says ELVN's lead drug, ELVN001, which has a different mechanism of action compared to Terns' drug, is best positioned for patients whose disease no longer responds to earlier treatments** Says TERN's lead drug, TERN701, is expected to compete mainly in earlier treatment settings** Adds ELVN is well positioned as a takeout target as most other CML drugs are owned by large drugmakers ** ELVN fell","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4N40D11F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","MRK","IE0009355771.USD","LU0006306889.USD","LU1941712264.USD","LU2360032135.SGD","LU1066053197.SGD","LU0648001328.SGD","LU0985320562.USD","LU1989771016.USD","BK4559","SG9999014542.SGD","LU0965508806.USD","LU0122379950.USD","LU0965509101.SGD","SG9999014567.USD","BK4533","LU1023059063.AUD","LU0106261372.USD","BK4534","ELVN","LU0070302665.USD","LU0477156953.USD","LU2468319806.SGD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0320765489.SGD","LU1066051225.USD","LU0320765646.SGD","BK4550","LU0889565916.HKD","LU0861579265.USD","LU1093756325.SGD","LU2023250504.SGD","SG9999001176.USD","LU1571399168.USD","LU1066051498.USD","LU1201861249.SGD","BK4007","LU1934455277.USD","BK4585","LU2023250843.SGD","LU0203345920.USD","SG9999002224.SGD","LU0868494617.USD","TERN","SG9999015358.SGD","LU1037948541.HKD","LU1116320901.HKD","LU2125154778.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622073857","title":"Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2622073857","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622073857?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:50","pubTimestamp":1774439436,"startTime":"0","endTime":"0","summary":"Shares of Enliven Therapeutics (ELVN) are up nearly 20% to $37.22 in pre-market trading after rival drug developer Terns Pharmaceuticals (TERN) ann...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-up-20-after-terns-pharmaceuticals-agrees-to-be-bought-by-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-up-20-after-terns-pharmaceuticals-agrees-to-be-bought-by-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","LU1162221912.USD","LU2112291526.USD","LU0289739699.SGD","LU1037948897.HKD","LU2125154935.USD","LU0208291251.USD","LU0320765489.SGD","LU1989772840.SGD","IE00BLSP4452.SGD","SG9999014575.USD","LU0122379950.USD","LU1093756168.USD","LU1983299246.USD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU2361044865.SGD","IE0009355771.USD","LU0965509101.SGD","LU0203345920.USD","LU1974910355.USD","LU1201861249.SGD","IE00BN8TJ469.HKD","BK4559","SG9999014559.SGD","LU0980610538.SGD","IE00B1BXHZ80.USD","IE0002141913.USD","IE00BBT3K403.USD","LU1941712264.USD","SG9999001176.USD","TERN","BK4516","LU0130517989.USD","LU1066051225.USD","LU1585245621.USD","SG9999014567.USD","LU1934455194.USD","LU0006306889.USD","BK4533","LU0109394709.USD","LU0265550946.USD","SG9999002232.USD","LU1023059063.AUD","LU0868494617.USD","LU1066053197.SGD","LU0098860793.USD","LU0238689110.USD","LU0965508806.USD","LU1699723380.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU0942090050.USD","IE00BLSP4239.USD","LU2125154778.USD","LU0985320562.USD","LU2360032135.SGD","SGXZ57979304.SGD","LU0130102774.USD","BK4550","LU1066051498.USD","BK4007","LU2361044949.HKD","LU0477156953.USD","LU2106854487.HKD","LU0203347892.USD","LU1941712348.USD","LU0106261372.USD","LU0965509283.SGD","LU1989771016.USD","LU1057294990.SGD","LU1929549753.HKD","LU0889565916.HKD","BK4588","LU0965509010.AUD","LU1035773651.USD","LU0320765646.SGD","LU2468319806.SGD","LU1093756325.SGD","LU2023250504.SGD","LU0058720904.USD","LU2324357040.USD","LU1069347547.HKD","LU0432979614.USD","ELVN","LU0648001328.SGD","LU1291159041.SGD","BK4585","LU1917777945.USD","LU1934455277.USD","SG9999015358.SGD","LU1934455863.HKD","LU1061106388.HKD","LU1116320737.USD","LU0234572021.USD","LU0211331839.USD","LU2089984988.USD","LU0868494708.USD","SG9999014542.SGD","LU1989772923.USD","BK4534","LU1116320901.HKD","LU0320765992.SGD","LU1571399168.USD","LU1430594728.SGD","LU0070302665.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU2461242641.AUD","IE00B2B36J28.USD","IE000M9KFDE8.USD","SG9999001440.SGD","SG9999015341.SGD","LU0266013472.USD","LU1037948541.HKD","LU0861579265.USD","LU2023250843.SGD","LU0265550359.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622023931","title":"U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2622023931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622023931?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:01","pubTimestamp":1774425680,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador ResourcesMarch 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wedn","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL8N40D0JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","AVAH","DINO","FIGG","HAL","AIR","AMZN","FIG","DK","FANG","DG","CVX","BP","GENB","KBH","BCAX","BPH","BZAI","CNM","BRZE","CVI","HD","CDE","FRPT","ABSI","BXP","AZYY","INSM","GLW","AARD","BAM","EVGO","CEG","BWXT","CEGX","USAW.SI","AMZD","APEI","ESE","MTDR","ARE","AMZU","ACAD","AVTX","CALM","AFG","ADUS","AMZP","BTM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620274932","title":"Enliven Therapeutics CMO Helen Louise Collins disposes of USD 138,800 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620274932","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620274932?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:51","pubTimestamp":1773957086,"startTime":"0","endTime":"0","summary":"Enliven reported a change in beneficial ownership by Chief Medical Officer Helen Louise Collins.On March 17, 2026, Collins exercised stock options and acquired 5,000 common shares at USD 2.48 per share.In the same set of transactions, she sold 5,000 common shares at a weighted average price of USD 27.76 per share.Following the reported transactions, Collins beneficially owned 25,000 common shares.She also reported holding 176,268 stock options after the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL7FdQ43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enliven Therapeutics CMO Helen Louise Collins disposes of USD 138,800 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979376","title":"Enliven Therapeutics CMO Helen Louise Collins Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979376","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618979376?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:33","pubTimestamp":1773264793,"startTime":"0","endTime":"0","summary":"Helen Louise Collins, Chief Medical Officer of Enliven Therapeutics Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL83FVR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enliven Therapeutics CMO Helen Louise Collins Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":99,"code":"91000000","status":"200"}]}}